RahulBanerjeeMDFACP

Hematologic Oncology

Assistant Professor, Division of Medical Oncology (focus: multiple myeloma)

Dr. Banerjee is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Dr. Rahul Banerjee, MD, FACP, (Twitter/X: @RahulBanerjeeMD) is an Assistant Professor at the Fred Hutchinson Cancer Center and at the University of Washington in Seattle, WA. His clinical interests are in multiple myeloma and CAR-T therapy. He is a member of the International Myeloma Working Group and has published over 80 peer-reviewed publications with an emphasis on improving the experiences of patients as they undergo treatment for multiple myeloma.

University of California San FranciscoAdvanced Fellowship, BMT/CAR-T Therapy, 2021 - 2022
University of California (San Francisco)Fellowship, Hematology and Medical Oncology, 2018 - 2021
University of Pennsylvania Health SystemChief Residency, Internal Medicine, 2017 - 2018
University of Pennsylvania Health SystemResidency, Internal Medicine, 2014 - 2017
University of Pennsylvania Health SystemInternship, Internal Medicine, 2014 - 2015
The Warren Alpert Medical School of Brown UniversityClass of 2014, MD, AOA Inductee

Winner, Department of Medicine ‘Shelter-in-Poetry’ Competition University of California San Francisco, 2020
Penn Pearls Award Recipient Perelman School of Medicine, University of Pennsylvania, 2017
Samaha Award for resident scholarship Penn Medicine, 2017
Inductee Gold Humanism Honor Society, 2013
Inductee Alpha Omega Alpha Honor Medical Society
Join now to see all

PubMed

Dexamethasone dose intensity does not impact outcomes in newly diagnosed multiple myeloma: a secondary SWOG analysis.
Rahul Banerjee, Rachael Sexton, Andrew J Cowan, Aaron S Rosenberg, Sikander Ailawadhi
Blood. 2025-01-02
2 citations
Mitigating time toxicity in lymphoma and multiple myeloma.
Mengyang Di, Christopher T Su, Andrew J Cowan, Ajay K Gopal, Rahul Banerjee
Leukemia & Lymphoma. 2024-10-01
Smartwatch Biometrics in the Electronic Medical Record: Time for a New Vital Sign?
Srishti Sankaran, Rahul Banerjee
JCO Clinical Cancer Informatics. 2024-09-01

Journal Articles

Illiteracy
Banerjee R, The Pharos of Alpha Omega Alpha Honor Medical Society, 2/21/2017

Books/Book Chapters

The 5-Minute Clinical Consult
Chapter: Autoimmune Hemolytic Anemia
Hue HJ, Lau ES, Banerjee REditors: Domino FJ.Lippincott Williams and Wilkins
The 5-Minute Clinical Consult
Chapter: Porphyria
Hue HJ, Lau ES, Banerjee REditors: Domino FJ.Lippincott Williams and Wilkins

Abstracts/Posters

Current Selection Patterns, Toxicities and Outcomes of Pre-Transplant Salvage Treatment Regimens in Patients with Relapsed/Refractory Hodgkin Lymphoma: Results of a Mu...
Rahul Banerjee, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019

Smoldering MM: Big Prevention Benefits with Daratumumab?December 16th, 2024
Smoldering MM: Big Prevention Benefits With Daratumumab?December 16th, 2024
IVIG Prophylaxis in Multiple Myeloma Cuts Infections, Boosts SurvivalDecember 8th, 2024
Join now to see all